Skip to search formSkip to main contentSkip to account menu

prothrombin complex concentrates

Known as: PPSB, cofact, factor IX concentrate 
National Institutes of Health

Related topics

Related topics

9 relations
ANTI-INHIBITOR COAGULANT COMPLEXfactor IX complex

Broader (2)

Blood Coagulation Factorprothrombin complex

Narrower (5)

KonyneOctaplexProplexProthrombinex

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2019
Review
2019
Prothrombin Complex Concentrates in Post-traumatic Hemorrhage: A Review
Review | Volume 5 | Issue 1| 1 2019 Karcioglu O. This is an open-access article distributed under Creative Commons Attribution 4… 
2017
2017
凝血酶原复合物联合小剂量利妥昔单抗治疗血友病B伴抑制物
目的 探讨血友病B伴抑制物的免疫耐受诱导（ITI）治疗，提高血友病B伴抑制物的诊疗水平。 方法 应用基于APTT标准曲线的一期法测定重型血友病B患者凝血因子Ⅸ（FⅨ）活性，应用Bethesda法进行FⅨ抑制物定量测定；利用凝血酶原复合物（PCC）进行ITI… 
2009
2009
The role of prothrombin complex concentrates in the treatment of hemophiliacs with factor VIII inhibitors.
While the presence of a Factor VIII inhibitor does not increase the frequency of bleeding, it does make treatment of bleeding… 
2005
2005
Zur Behandlung des Faktor-II-VII- und-X-Mangels mit P.P.S.B.
ZusammenfassungÜber eine Zeit von 8 Monaten konnte im Rahmen einer konsequent alle 10 Tage durchgeführten Substitutionstherapie… 
2005
2005
Regular prophylaxis with recombinant factor VIIa in a patient with severe congenital FVII deficiency
Regulare Prophylaxe mit rekombinantem Faktor VIIa bei einer Patientin mit schwerem angeborenen FVII-Mangel - 
1996
1996
Eigenschaften und Indikationen von PPSB-Konzentraten unter besonderer Berücksichtigung der Qualitätssicherung sowie flankierender therapeutischer Maßnahmen
Ziel: Es werden wichtige Aspekte fur die Anwendung von PPSB-Konzen-traten vorgestellt unter Berucksichtigung der Eigenschaften… 
1993
1993
[Biotest position on HIV-1 seroconversions in 1990 in 11 patients, treated with beta-propiolactone/uv virus inactivated PPSB].
1987
1987
Influence of inhibitors on the thrombogenicity and toxicity of prothrombin complex concentrates.
Patients treated with prothrombin complex concentrates (PCCs) have frequently been found to develop arterial thrombosis, venous… 
1977
1977
Thrombogenic properties of prothrombin complex concentrates.
In a recent paper White et al.’ reported that the thrombogenic properties of prothrombin complex concentrates (PCC) are due to… 
1966
1966
Kongenitaler kombinierter Mangel der Faktoren II, VII und X
ZusammenfassungAn Hand einer eigenen Beobachtung eines kongenitalen Mangels der Faktoren II, VII und X, welche die erste in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)